Technow Plans Biologics as BIOVECTRA Pillar
As Charlottetown-based drug manufacturer BIOVECTRA launches its new, $90 million biomanufacturing facility, CEO Oliver Technow says expansion of its production capacity is an important part of its plans to stay internationally competitive.
BIOVECTRA was the only Atlantic Canadian company last year to crack Ontario-based Communitech’s inaugural Team True North list of startups that are on track